The Molecular Basis of Vascular Disorders  by Towbin, Jeffrey A. et al.
Am. J. Hum. Genet. 64:678–684, 1999
678
HUMAN GENETICS ’99: THE CARDIOVASCULAR SYSTEM
The Molecular Basis of Vascular Disorders
Jeffrey A. Towbin,1,2 Brett Casey,3 and John Belmont2
Departments of 1Pediatrics (Cardiology), 2Molecular and Human Genetics, and 3Pathology, Baylor College of Medicine, Texas Children’s
Hospital, Houston
Cardiovascular malformations occur in a large number
of hereditary or sporadic diseases. Here, we review the
general pathway by which the vasculature develops, and
we discuss the etiology of several groups of diseases in
which cardiovascular development or maintenance go
awry. Many such abnormalities are also observed in an-
imals, including mice and zebrafish, the latter being an
emerging model genetic organism that has already
proved useful in the study of the development of the
circulatory system. In many respects, morphogenesis in
the heart and the vasculature presents challenges that
are similar to corresponding events elsewhere in the
body. Indeed, many of the diseases discussed here present
with a range of effects in other tissues, suggesting that
some of the regulatory pathways are shared. Still, blood
flow is a unique feature of the heart and the vessels, and
we will consider genetic and physiological evidence that
blood flow helps shape these organs during develop-
ment.
Development of the Vascular System
Embryonic blood vessel development (depicted in fig.
1) requires two distinct morphological events: vasculo-
genesis and angiogenesis. Vasculogenesis occurs by in
situ differentiation of mesodermal cells—angioblasts
(Cleaver and Krieg 1998)—into endothelial cells, which
line the interior wall of vessels. During early embryonic
development, angioblasts coalesce to form clusters,
which then join to form the vessels, including the dorsal
aorta, the endocardium, and the major veins (cardinal
and vitelline). Hemangioblasts, also derived from em-
bryonic mesoderm, line the floor of the anterior dorsal
aorta and contribute to both the definitive hematopoietic
stem cells and the aortic endothelium (Cleaver and Krieg
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1998). Angiogenesis, the outgrowth and branching from
existing vessels, is responsible for the elaboration of the
primitive vascular structures. Remodeling plays a critical
role in vessel maturation, particularly in the aortic arches
in which the vessels enlarge, join, or regress. After the
initial formation of a vessel, vascular walls develop by
recruiting other cellular and extracellular components.
Mesenchymal cells surrounding the endothelium are re-
cruited and differentiate into vascular smooth muscle
cells (Walsh et al. 1998). In the great vessels, the smooth
muscle cells are derived, in part, from the neural crest,
whereas in other tissues or smaller vessels, these cells
derive from the surrounding mesoderm (Walsh et al.
1998).
In vitro studies and, more recently, targeted mutations
in mice have helped to define some of the inductive
growth factors, receptors, and transcription factors reg-
ulating vessel formation. These include fibroblast growth
factors, vascular endothelial growth factor and its re-
ceptors flk-1 and flt-1, transforming growth factor b
(TGF-b) (see Ring and Cho 1999 [in this issue]), and
angiopoietin-1 and -2, along with one of their receptors
tie-2. The phenotype of mice mutant for Vegf and Flk-
1 reveal that these genes are required in embryonic vas-
culogenesis. Mutation leads to failure of vessel coales-
cence, with resulting defects in both endothelial and he-
matopoietic development. Tie-2 mutants develop a
primitive vasculature but die in midgestation with mul-
tiple hemorrhages and abnormal cardiac development,
presumably because of failure of endothelial prolifera-
tion (Vikkula et al. 1996). Endothelins and their recep-
tors are essential for development of subsets of neural
crest cell derivatives, and endothelin pathway mutations
cause defects in cardiac outflow and great vessel struc-
tures derived from cephalic neural crest. These mutants
demonstrate abnormal arterial regression, and the con-
sequent disturbance of asymmetrical remodeling of the
arch arteries may lead to interrupted aortic arch, hy-
poplasia of the aortic arch, and ventricular septal defects.
Mice with a mutation in the cytosolic component of the
transcription factor—nuclear factor of activated T cells
(NF-ATc)—fail to develop normal cardiac valves and
septa. NF-ATc expression in the early embryo is re-
stricted to the endocardium, a specialized endothelium
Figure 1 Genetic defects affect various stages of cardiovascular development. Mutants from zebrafish, mouse, and human relating to primary developmental processes or maintenance of the
vascular system. A, Vasculogenesis and angiogenesis. B, Embryonic development of the vascular system. C, Obstruction of the left ventricular outflow tract leading to hypoplastic left heart syndrome.
Note the small left ventricle (LV), atretic aortic and/or mitral valves, with aortic hypoplasia.
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that gives rise to the valves and septum. Several zebrafish
mutants also affect the vascular development. Of these,
the best studied may be the cloche mutant, in which
endocardial and endothelial development and hemato-
poiesis are disrupted. Animal model studies should allow
the eventual definition of the most important develop-
mental pathways and help in the identification of human
homologues that contribute to cardiovascular disease,
including many of those discussed in this report.
Abnormalities of the Aorta and the Left Side of the
Heart
The left side of the heart and its outflow into the aorta
may be affected because of obstruction and vascular
diminution or dilatation of the great artery and left ven-
tricular chamber. In most, but not all, cases, these vas-
cular defects occur as part of a syndrome. The best-
described obstructive disorder is supraventricular aortic
stenosis (SVAS), which may occur as an isolated con-
dition or as part of Williams syndrome (WS). Marfan
syndrome (MFS) is the best known of the disorders as-
sociated with aortic dilatation. Other disorders, such as
hypoplastic left heart syndrome (HLHS), coarctation of
the aorta (COA), and Ehlers-Danlos syndrome (EDS)
have significant aortic lesions.
Obstruction of the Aorta in HLHS
HLHS occurs typically as a diminutive left ventricular
chamber with aortic atresia and mitral atresia. The as-
cending aorta is usually quite small, and the systemic
circulation is dependent on a patent ductus arteriosus
(fig. 1C). The most widely accepted hypothesis is that
HLHS develops because of embryonic alterations in
blood flow (Clark 1986; Ferencz et al. 1997).
Cardiac morphogenesis apparently requires both in-
trinsic processes of pattern formation and blood-flow-
directed remodeling. Intracardiac streaming of the sys-
temic venous (future right ventricle) and pulmonary ar-
terial (future left ventricle) blood begins before ventric-
ular septation is complete, and flow may play a role in
directing the process of chamber formation (Clark 1986;
Ferencz et al. 1997). The left ventricular outflow tract
(LVOT) obstruction defects account for 15%–20% of
congenital heart defects (CHD). LVOT obstruction le-
sions include aortic valve stenosis (AS), SVAS, COA, and
HLHS; bicuspid aortic valve may occur in asymptomatic
parents and first-degree relatives of probands with AS,
COA, and HLHS. These defects appear to arise from
defective flow in the LVOT during early embryogenesis.
Available relative recurrence risk data for LVOT ob-
structive defects would be consistent with 70% of the
variance on the inferred underlying liability distribution
accounted for by genetic factors.
Normal blood flow is apparently required for mod-
eling and growth of myocardium and valve, as well as
the vascular structures. This hypothesis is supported by
the observation in animal models that imposition of out-
flow tract obstruction leads to structural defects (Lyons
et al. 1995). Prenatal ultrasound has given additional
insight into the evolution of left ventricular growth in
HLHS. The observation of worsening of left ventricular
disproportion as fetal growth proceeds possibly indicates
a role of obstructed flow in suppressing left ventricular
growth but might also be compatible with a more com-
plex mechanism in which an intrinsic defect in myocar-
dial growth interacts with an increasingly severe ob-
struction. Several mouse mutations (Fishman and Chien
1997) affect myocardial growth and produce thin ven-
tricular walls that may be prone to septal defects.Mouse
genes implicated include CXC, NT-3, TEF-1, WT-1,
Neuregulin, ERB2, and ERB4, and it was recently
shown that the transcription factor NF-ATc is required
for normal valvulogenesis in mice. Mutations in en-
dothelin 1, endothelin-A receptor, Hand2, MFH-1, and
the retinoid receptor genes can all lead to aortic arch
malformations, as can gridlock mutations in zebrafish.
SVAS and WS
SVAS is an obstructive vascular disease with an esti-
mated incidence of 1 in 20,000 births and autosomal
dominant inheritance (Schmidt et al. 1989) or sporadic
onset. Any artery of the body may be affected in inher-
ited SVAS; it is the aortic involvement that is most often
responsible for clinical outcome. Arterial lesions are var-
iable. Pathological findings (O’Connor et al. 1985) in-
clude loss of normal parallel orientation of elastic fibers,
resulting in a disordered array of elastic fibers and hy-
pertrophied smooth muscle cells. Hyperplasia of elastic
tissue in the media of the arteries usually occurs. Inmany
cases of SVAS, the initial arterial lesion is peripheral
pulmonic stenosis, which in most cases improves with
time (Giddins et al. 1989). SVAS is a common finding
in WS, a contiguous gene–deletion syndrome that is oc-
casionally inherited. In addition to the cardiac malfor-
mation, individuals with WS (Morris 1998) exhibit mild
mental retardation, dysmorphic facial features, hyper-
calcemia of infancy, and a unique personality described
as a “cocktail party personality.” The cardiovascular ab-
normalities are identical to those found in familial SVAS.
Both SVAS and WS are linked to chromosome 7q,
where the elastin gene (7q11.23) maps (Morris 1998).
ELN rearrangements, point mutations, deletions, splice
site mutations, and nonsense mutations have been found
in families and sporadic cases of SVAS or WS. Elastin
is an extracellular matrix protein that comprises 90%
of the elastic matrix that restores a vessel’s shape after
it has been stretched. The precise mechanism by which
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haploinsufficiency for ELN leads to human arterial pa-
thology is unknown. Since Eln knockout mice show ev-
idence of structural abnormality of the arterial wall, the
animal model could elucidate the pathogenesis of SVAS.
The region surrounding ELN includes multiple genes
that may account for the complex set of WS symptoms.
gridlock and Aortic Coarctation
Coarctation of the aorta is defined as an abrupt con-
striction situated in the aortic isthmus between the origin
of the left subclavian artery proximally and the aorto-
ductus arteriosus distally, resulting in an obliterative or
obstructive “curtain lesion” (Ho and Anderson 1979).
This congenital lesion is the most common congenital
anomaly of the aortic arch in humans, occurring in
5%–8% of children with congenital heart defects, and
can have devastating consequences in infants. Familial
inheritance has been described, usually with autosomal
dominant transmission. The etiology of this arterial le-
sion continues to remain elusive. However, insight into
the potential molecular causes of this disorder was sug-
gested by Weinstein et al. (1995), who described a ge-
netic mutation called gridlock in the zebrafish.
The gridlock mutation is an autosomal recessive mu-
tation brought about by saturation mutagenesis studies
of the zebrafish genome. This mutation generates ab-
normal vascular development, specifically a failure of
vascular channel formation at the site where the bilat-
erally paired dorsal aortae join together and continue
posteriorly as a single dorsal midline channel (the medial
dorsal aorta). In some genetic backgrounds, Weinstein
et al. (1995) found the anomaly to be associated with
development of a major arteriovenous (A-V) shunt,
whereas in other backgrounds, A-V shunting failed to
develop, but extensive collateral vessels were recruited
to connect the anterior circulation (including the heart)
with the posterior medial dorsal aorta. Blood flow to
the tail was impeded by the localized vascular defect
from blockage in the anterior trunk, where the paired
lateral dorsal aortae normally merge to form the single
midline aorta. Although not exactly the same as coarc-
tation of the aorta (Towbin and McQuinn 1995), this
mutant certainly represents a genetic locus that specifi-
cally affects a localized aspect of vascular development
and provides a model system for the study of disorders
of the major vasculature of humans. This model could
provide supportive evidence for the most likely hypoth-
esis of obstruction of the left side of the heart—
abnormalities of blood flow.
Dilation of the Aorta: MFS and EDS
MFS, a heritable disorder of connective tissue, is
caused by a defect in fibrillin protein encoded by the
FBN1 gene on chromosome 15 (15q15-q20) (Milewicz
1998). It has been estimated that MFS occurs in ∼1 in
10,000 individuals, but its clinical expression is variable
and may include overlap with nonpathological features
(such as tall stature) that can be observed in the general
population. MFS affects the skin and the skeletal, ocular,
pulmonary, and central nervous systems and commonly
leads to cardiovascular abnormalities, including those of
the mitral apparatus and aorta. Other disorders share
some of the same phenotypes; congenital contractural
arachnodactyly has sometimes been described as a sub-
type of MFS or a separate disorder, but recent data sug-
gest that it arises through defects in the fibrillin-2 gene
on 5q23-q31 (Milewicz 1998). Fibrillin-1 is a large gly-
coprotein with a molecular weight of 350 kD and is a
component of the microfibrils that are ubiquitous in the
connective tissue space. FBN1 defects have also been
found in patients with severe neonatal MFS, and in in-
dividuals with atypical symptoms such as autosomal
dominant ectopia lentis, the MASS phenotype (mitral
valve, aorta, skeleton, and skin), or isolated ascending
aortic aneurysm with dissection.
EDS comprises a group of conditions that presentwith
markedly loose joints and with easy bruising of the skin.
Of the four most common forms of EDS (types I–IV),
type I and type IV are discussed here. The features of
EDS type I include hyperextensible and fragile skin, hy-
perextensibility of the joints, and cardiovascular disease
(De Paepe et al. 1997), particularly mitral valve prolapse,
tricuspid valve prolapse, and aortic root and/or sinus of
Valsalva dilation. As in MFS, in EDS the most significant
cardiovascular defect is the increased susceptibility to
dissecting aortic aneurysm, which can lead to death. EDS
type I is inherited as an autosomal dominant disorder
with variability in expression. The defect in this disorder
involves synthesis of normal collagen, and mutations in
the type V collagen genes COL5A1 (De Paepe et al.
1997) and COL5A2 genes (Michalickova et al. 1998)
have been reported. In addition, mutant mice with
Col5a2 deletions have been created with phenotypic re-
semblance to that of EDS type I (Andrikopoulos et al.
1995). The type V collagen is qualitatively a minor com-
ponent of connective tissues that are rich in type I col-
lagen (bone, tendon, ligament, cornea, and dermis), but
it appears to play a critical role in determining the di-
ameter of the heterotypic collagen fibrils in these tissues.
Abnormal collagen fibrillogenesis is responsible for the
severe vessel and dermal fragility and joint laxity seen
in patients because of the reduction in the amount of
normal type V collagen available for collagen fibril-
logenesis.
The autosomal dominant disorder EDS type IV is
sometimes referred to as the malignant form of EDS,
since there is marked susceptibility to spontaneous rup-
ture of the bowel or of any of the large blood vessels.
The hyperelasticity and hyperextensibility tend to be less
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obvious than in EDS type I. However, easy bruising and
bleeding are very prominent. The type III collagen gene
(COL3A1) appears to underlie EDS type IV (Milewicz
1998); defects in this gene have been reported and in-
clude point mutations altering glycine residues within
the triple helical domain of type III collagen, exon splic-
ing errors deleting a single exon but usually maintaining
the reading frame of the protein, or multiexon deletions.
The molecular mechanism in which COL3A1 muta-
tions lead to disease is felt to be a dominant negative
pathogenesis, similar to that of FBN1 mutations (Mi-
lewicz 1998). Mutations in one COL3A1 allele lead to
the production of a mutant proa1 polypeptide. Because
type III collagen is a homotrimer of proa1, when ab-
normal proa1 is incorporated into type III collagen, the
great majority of the type III collagen molecules pro-
duced will be abnormal. The abnormal type III collagen
is inefficiently secreted, leading to diminished amounts
of type III collagen in the matrix.
Abnormalities of the Pulmonary Artery and Right Side
of the Heart
Similar to obstructive lesions in the left side of the
heart, obstruction of the right side of the heart and pul-
monary arteries leads to cardiovascular compromise. In
addition, these abnormalities are most commonly as-
sociated with complex syndromes such as the CATCH-
22 syndromes (DiGeorge syndrome (DGS)–velocardio-
facial (VCF) syndrome phenotype) and Alagille syn-
drome.
CATCH-22 Syndromes
The combination of dysmorphic features, palatal ab-
normalities, thymic hypoplasia, parathyroid hypoplasia,
and cardiac defects has been termed DGS (Scambler
1993). The thymic, parathyroid, and cardiac defects all
result from developmental abnormalities of the third and
fourth branchial arches and neural crest. The estimated
frequency of this disorder is 1 in 4,000 live births. Similar
disorders—VCF and conotruncal face anomaly (CTFA)
syndrome—have similar findings and are clinically
grouped with DGS as the so-called CATCH-22 dis-
orders.
Defects in neural crest–derived cardiac structures are
an important feature comprising ∼15% of all CHD. Ac-
cording to the classification system of Clark (1986), the
two types of defects associated with DGS (and with VCF
and CTFA) are conotruncal defects and branchial arch
mesenchymal tissue defects. Among conotruncal defects,
truncus arteriosus is the most common type. Among the
branchial arch mesenchymal tissue defects, interrupted
aortic arch type b and right aortic arch are the most
common. Other lesions include tetralogy of Fallot (de-
fined as pulmonary stenosis with ventricular septal de-
fect, overriding aorta, and right ventricular hypertro-
phy), double-outlet right ventricle, transposition of the
great arteries, and absent pulmonary valve syndrome.
Multiple etiologies for DGS have been found, includ-
ing chromosome abnormalities, single-gene defects, and
teratogenic exposures. Approximately 15% of infants
with DGS can be found to have obvious chromosome
abnormalities, of which about two-thirds involve amon-
osomy 22q11. This usually results from an unbalanced
translocation involving chromosome 22 and another
chromosome. FISH analysis with probes from the critical
region have shown that a total of ∼85% of DGS patients
carry deletions in 22q11 (Scambler 1993). A critical re-
gion appears to encompass at least nine genes that are
found over a 480-kb interval (Funke et al. 1998). It is
likely that haploinsufficiency of one or more of these
genes in this interval contributes to the etiology of this
disease in most patients. However, two nonoverlapping
regions of chromosome 10p have also been found to be
deleted in some patients with DGS, raising the possibility
of genetic heterogeneity (Gottlieb et al. 1998).
No detailed pathway is yet known for cardiac neural
crest migration, but several genes have been identified
that may be relevant to the etiology of the CATCH-22
syndromes. Mice bearing a mutation for the homeobox
transcription factorHoxa3 have aortic arch defects rem-
iniscent of DGS, and a subset of Pax3-deficient mice
have similar defects (Belmont 1998). Additional muta-
tions in the transcription factors Rxra and Sox4 and in
the Nf1 gene give conotruncal and ventricular septation
abnormalities typical of altered neural crest integration.
Interestingly, various CHD have recently been noted to
occur in ∼1.6% (threefold relative risk) of individuals
with NF1.
Alagille Syndrome
Alagille syndrome primarily affects the liver, heart,
eye, and spine (Krantz et al. 1997), but 10%–20% of
affected infants also exhibit cardiac defects, primarily
pulmonic stenosis. This disorder appears to be inherited
with autosomal dominant transmission and variable
expression.
The general map location for Alagille syndrome was
provided by the observation of rearrangements and de-
letions in 20p12. However, !10% of patients with Al-
agille syndrome carry such lesions, and point mutations
in a human homologue of Drosophila jagged gene
(JAG1) are sufficient to cause the condition (Li et al.
1997; Oda et al. 1997). JAG1 encodes a ligand for
Notch, a cell surface receptor that was originally defined
in studies of fly wing morphogenesis. Both jagged and
Notch homologues have been identified in humans and
rodents. Mice deficient in NOTCH1 or Delta (another
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Notch ligand) show defects in somite development that
may correlate with the vertebral anomalies in observed
Alagille syndrome. JAG1 mutations have recently been
identified in children with tetralogy of Fallot but with
no evidence of Alagille syndrome.
Abnormalities of Laterality
In some cases, the great vessels and systemic veins are
malpositioned with or without malposition of the car-
diac chambers of abdominal organs. The causes of these
complex abnormalities of laterality have recently begun
to unfold.
Rightward looping of the midline heart tube is the
first overt manifestation of anatomic left-right (LR) dif-
ferences, which eventually come to include the asym-
metry of the lungs and most of the unpaired organs of
the abdomen (Casey 1998). Heart malformations as-
sociated with abnormal looping, therefore, usually occur
as one manifestation of a more global abnormality of
LR-axis development. The typical patient presents with
complex structural heart anomalies, abnormalities of
spleen position and/or number, and some degree of gut
malrotation. The overall LR anatomy of this individual
might be described as situs ambiguus, or indeterminate
sidedness, in contrast to situs solitus (normal sidedness)
and situs inversus (complete LR reversal). Manifesta-
tions are quite variable, however, even among affected
individuals from the same family.
Heart malformations attributable to abnormal later-
ality represent 3.4% of all cardiac defects (1.44 in
10,000 live births) (Ferencz et al. 1997, pp. 165–225).
The familial clustering of situs shows that genetics con-
tributes significantly to these abnormalities, and several
mutant mouse lines with similar defects are known
(Casey 1998). Molecular genetic studies have yielded
some support for this hypothesis. One locus for human
situs defects was mapped to Xq26.2 (Casey 1998),where
the gene for the zinc-finger transcription factor ZIC3
resides. ZIC3 mutations occur among sporadic and fa-
milial cases (Casey 1998), but they are relatively rare
(K. Kosaki and B. Casey, unpublished data), which is
not surprising given the similar incidence of disease
among males and females and the variety of inheritance
patterns seen among familial cases.
Studies in other vertebrates are yielding additional
candidate genes for human LR abnormalities. For ex-
ample, several genes are asymmetrically expressed along
the LR axis in chick prior to the development of ana-
tomic LR asymmetry (Levin 1997). Some of these genes
are also asymmetrically expressed in mouse, including
nodal and pitx2, as well as lefty-1 and lefty-2, two TGF-
b family members (see Ring and Cho 1999) whose chick
orthologues have yet to be identified (Casey 1998). Ge-
netic studies in mice have also implicated several addi-
tional genes in LR axis development in which asym-
metric expression has not been detected, including
HNF3b, ActrIIb, and Smad2 (Casey 1998). Mutation
analysis has been carried out on a large panel of situs
ambiguus cases for human homologues of nodal,
HNF3b, ActRIIb, and lefty-1 and lefty-2. A small num-
ber of mutations have been detected in each (Casey
1998; Kosaki et al. 1999).
Other Vascular Growth Defects
Connection of the pulmonary veins to the left atrium
involves fusion of the common pulmonary vein to the
primitive left atrium. Failure of connection has been at-
tributed to abnormal targeted growth, although direct
evidence is lacking. The resulting defects (total anom-
alous pulmonary venous return [TAPVR] or partial
anomalous pulmonary venous return, cor triatriatum,
etc.) reflect establishment of abnormal pulmonary vein
connections or incomplete connection. The repeated oc-
currence of these defects in at least two genetic abnor-
malities—tetrasomy 22q (cat eye syndrome) and familial
TAPVR (i.e., pulmonary venous return entering into the
right side of the heart instead of the left atrium in mul-
tiple family members)—strongly suggests that they form
a distinct mechanistic class. Dominant mutations in the
growth factor endoglin (McAllister et al. 1994) and an
activin-like receptor (Marchuk 1998) lead to the hered-
itary hemorrhagic telangiectasias (see Ring and Cho
1999). Individuals with these disorders have multiple
small vascular anomalies but may have very significant
pulmonary or cerebral arterial-venous malformations.
Two families with this rare disorder have been reported
showing vascular repair defects associated with the
growth factor receptor Tie-2 mutations (Vikkula et al.
1996).
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